Kyverna Therapeutics Inc.

NASDAQ: KYTX · Real-Time Price · USD
3.21
0.27 (9.18%)
At close: Jun 06, 2025, 12:55 PM
9.18%
Bid 3.21
Market Cap 138.95M
Revenue (ttm) n/a
Net Income (ttm) -145.42M
EPS (ttm) -3.36
PE Ratio (ttm) -0.96
Forward PE -0.91
Analyst Buy
Ask 3.22
Volume 245,192
Avg. Volume (20D) 316,722
Open 3.07
Previous Close 2.94
Day's Range 3.07 - 3.31
52-Week Range 1.78 - 16.64
Beta 2.54

About KYTX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KYTX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KYTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
+13.66%
Kyverna Therapeutics shares are trading higher aft... Unlock content with Pro Subscription
10 months ago
+1.23%
Kyverna Therapeutics shares are trading higher after the company announced it received FDA Regenerative Medicine Advanced Therapy designation for KYV-101 in the treatment of patients with refractory stiff-person syndrome.